Analysis of Recombinant Human Bone Morphogenetic Protein-2 Use in the Treatment of Lumbar Degenerative Spondylolisthesis

@inproceedings{Yao2016AnalysisOR,
  title={Analysis of Recombinant Human Bone Morphogenetic Protein-2 Use in the Treatment of Lumbar Degenerative Spondylolisthesis},
  author={Qingqiang Yao and Jeremiah Raphael Cohen and Zorica Buser and J Y Park and Darrel Scott Brodke and H. H. Meisel and Jim A. Youssef and Jeffrey C Wang and Sangwook Tim Yoon},
  booktitle={Global spine journal},
  year={2016}
}
Study Design Retrospective database review. Objective To identify trends of the recombinant human bone morphogenetic protein-2 (rhBMP-2) use in the treatment of lumbar degenerative spondylolisthesis (LDS). Methods PearlDiver Patient Record Database was used to identify patients who underwent lumbar fusion for LDS between 2005 and 2011. The distribution of… CONTINUE READING